NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS Accenture ( ACN) downgraded at Baird from Outperform to Neutral. Valuation call, based on a $62 price target. BlackRock ( BLK) downgraded to hold by TheStreet Ratings. Cypress Semiconductor ( CY) numbers cut at Sterne Agee.CY estimates were reduced through 2013. Company will likely see lower Touchpad and Playbook sales. SRAM demand is also falling. Buy rating and new $21 price target. Diamond Foods ( DMND) upgraded at Jefferies from Hold to Buy. Valuation call, based on a $94 price target. Dollar Tree ( DLTR) numbers raised at Goldman.Shares of DLTR now seen reaching $75. Estimates also increased, as the company is buying back more stock. Neutral rating. Emerson ( EMR) downgraded at BofA/Merrill from Buy to Neutral. $54 price target. Estimates also lowered, as the company is leveraged to slower economic growth -- especially in Europe. Global Industries ( GLBL) upgraded to hold by TheStreet Ratings. Hasbro ( HAS) estimates, target cut at Needham.Shares of HAS now seen reaching $42. Estimates also reduced, as industry sales appear to be slowing. Humana ( HUM) estimates increased at Jefferies through 2012. Company should benefit from a low-cost operating environment. Buy rating and $89 price target. Mead Johnson ( MJN) numbers raised at Credit Suisse. Shares of MJN now seen reaching $82. Estimates also increased, given improving operating leverage. Outperform rating. Medco Health ( MHS) numbers lowered at BMO. Shares of MHS now seen reaching $55. Estimates also cut, given reduced pill volumes. Market Perform rating. Micron ( MU) upgraded at Citi to Buy. $7 price target. Stock is attractive, following a 16% pullback. MSC Industrial ( MSM) downgraded at BofA/Merrill from Buy to Neutral. Estimates also cut, as the company could struggle to expand its margins. $74 price target. Nasdaq ( NDAQ) estimates upped at UBS through 2012. Trading volume continues to grow year-over-year. Buy rating and $28 price target. Pepsico ( PEP) estimates, target lowered at UBS.PEP estimates were cut through 2012. Company is seeing decelerating sales growth. Buy rating and new $72 price target. Potash ( POT) upgraded at Ticonderoga from Neutral to Buy. Valuation call, based on a $62 price target. Sirius XM ( SIRI) numbers reduced at Morgan Stanley. Shares of SIRI now seen reaching $2. Estimates also cut, given lower expected revenue per user. Overweight rating.
Southwest Airlines ( LUV) downgraded at Deutsche from Buy to Hold. $9 price target. AAI acquisition will boost costs. Sprint Nextel ( S) downgraded at Collins Stewart to Neutral. $3 price target. Company is spending more on CapEx. Sprint Nextel downgraded at Deutsche from Buy to Hold. $3 price target. Company could lose 4G market share to Verizon and AT&T. Sprint Nextel downgraded at JP Morgan from Overweight to Neutral. Network build and iPhone spending will cut into earnings. Sprint Nextel downgraded at Kaufman to Hold. $2.50 price target. Company is leveraging up its balance sheet to pay for LTE expansion. St. Jude Medical ( STJ) upgraded at Morgan Stanley from Underweight to Equal-weight. Stock is already pricing in lower CRM market growth. SuccessFactors ( SFSF) downgraded at BMO from Outperform to Market Perform. $26 price target. Checks show that industry demand is beginning to slow. Texas Instruments ( TXN) numbers boosted at UBS. TXN estimates were upped through 2013. NSM purchase should add to earnings. Outperform rating and $40 price target. Treehouse Foods ( THS) downgraded at BofA/Merrill from Buy to Neutral. Valuation call, as the stock is up 20% year-to-date. $64 price target.